Simplex Trading, LLC Infinity Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.49 - $1.2 $2,401 - $5,881	-4,901 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$0.85 - $2.4 $53,862 - $152,083	-63,368 Reduced 92.82%	4,901 $5,000
Q4 2021 Feb 23, 2022	BUY	$1.86 - $3.36 $8,105 - $14,642	4,358 Added 6.82%	68,269 $153,000
Q2 2021 Aug 12, 2021	BUY	$2.66 - $3.47 $22,737 - $29,661	8,548 Added 15.44%	63,911 $191,000
Q1 2021 Apr 26, 2021	BUY	$1.98 - $5.36 $96,285 - $260,651	48,629 Added 722.14%	55,363 $178,000
Q4 2020 Feb 02, 2021	BUY	$1.05 - $2.77 $7,070 - $18,653	6,734 New	6,734 $14,000
Q2 2019 Jul 26, 2019	SELL	$1.43 - $1.87 $1,285 - $1,681	-899 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$1.18 - $1.91 $1,152 - $1,866	-977 Reduced 52.08%	899 $0
Q4 2018 Jan 16, 2019	SELL	$1.01 - $2.78 $69,326 - $190,819	-68,640 Reduced 97.34%	1,876 $2,000
Q3 2018 Oct 23, 2018	BUY	$1.72 - $2.71 $107,764 - $169,792	62,654 Added 796.92%	70,516 $191,000
Q2 2018 Jul 30, 2018	SELL	$1.72 - $2.26 $38,822 - $51,010	-22,571 Reduced 74.17%	7,862 $15,000
Q1 2018 Apr 26, 2018	BUY	$1.8 - $2.74 $3,578 - $5,447	1,988 Added 6.99%	30,433 $63,000
Q4 2017 Jan 10, 2018	BUY	$1.22 - $3.73 $26,458 - $80,892	21,687 Added 320.91%	28,445 $57,000
Q3 2017 Oct 25, 2017	BUY	$0.94 - $1.35 $6,352 - $9,123	6,758	6,758 $8,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.